Skip to content

effectiveness of Efflorage massage on the limb edema

Investigating the effectiveness of Efflorage massage on the limb edema in hospitalized patients in intensive care unit

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250419065389N1
Enrollment
66
Registered
2025-06-04
Start date
2025-05-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower limb edema.

Interventions

Intervention 1: Intervention group: The first intervention group receives Eflorage massage for seven days and also receives routine measures to control edema. This massage is performed for ten minutes

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The patient must be hospitalized in the intensive care unit and under a ventilator. Patients hospitalized in the intensive care unit or their legal guardians (patients who do not have sufficient awareness and consciousness) must be willing to participate in the study. A maximum of 24 hours must have passed since the patient was hospitalized in the intensive care unit. - No occurrence of deep vein thrombosis according to reports recorded in the medical record and clinical symptoms (including a difference in the circumference of the legs of more than 3 cm, tenderness and redness of one leg, and a positive Homan sign). The patient must be 18 years of age or older.The patient should not move in bed. Should not have increased intracranial pressure. The patient should not have active bleeding, skin diseases, advanced burns in the limbs. The patient should not have amputation, fracture or surgery in the upper or lower limbs and deep vein thrombosis. The patient should not be allergic to olive oil. Should not have Permocet, Angiocet and access in the lower limbs.

Exclusion criteria

Exclusion criteria: Unwillingness to continue to cooperate in the study. Death or discharge or transfer of the patient to another department during the study. Starting or stopping medications that can cause edema (calcium channel blockers, nonsteroidal anti-inflammatory drugs, oral contraceptives, steroids, gabapentin, amilodipine). Development of symptoms of deep vein thrombosis. Starting or stopping diuretics.

Design outcomes

Primary

MeasureTime frame
Mean lower limb peripheral measurements and lower limb edema grading based on the pitting edema scale. Timepoint: For eight days before the intervention. Method of measurement: Tape measure for measuring limb circumference and a dimple edema scale for grading edema.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomayeh Ghaffari

Esfahan University of Medical Sciences

somayehghafari@nm.mui.ac.ir+98 21 3668 7153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026